Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

IDT Australia Ltd

Healthcare AU IDT

0.036AUD
-0.001(2.70%)

Last update at 2026-06-05T02:29:00Z

Day Range

0.040.04
LowHigh

52 Week Range

0.030.11
LowHigh

Fundamentals

  • Previous Close 0.04
  • Market Cap15.81M
  • Volume130709
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.27000M
  • Revenue TTM19.00M
  • Revenue Per Share TTM0.04
  • Gross Profit TTM 11.30M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -8.06300M -6.07500M -9.77600M -1.87600M 0.97M
Minority interest - - - - -
Net income -8.06300M -5.41300M -8.49800M -1.16000M 2.10M
Selling general administrative 0.61M 1.39M 9.78M 7.08M 12.31M
Selling and marketing expenses 14.69M 10.62M - - -
Gross profit 9.69M 10.42M 4.75M 10.66M 14.15M
Reconciled depreciation 0.86M 0.93M 1.04M 1.54M 1.78M
Ebit -7.40000M -6.48900M -9.87300M -1.90100M 0.07M
Ebitda -6.54000M -5.56400M -8.83400M -0.36500M 1.85M
Depreciation and amortization 0.86M 0.93M 1.04M 1.54M 1.78M
Non operating income net other - - - - -
Operating income -6.31400M -6.85100M -9.77600M -1.87600M 0.97M
Other operating expenses 26.08M 20.08M -6.02600M -4.48000M -4.82400M
Interest expense 0.76M 0.12M - 0.03M 0.90M
Tax provision 0.00000M -0.66200M -1.27800M -0.71600M -1.13700M
Interest income 0.10M 0.10M - - 0.03M
Net interest income -0.66300M -0.01700M - - 0.03M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.23800M -0.66200M -1.27800M -0.71600M -1.13700M
Total revenue 19.77M 13.23M 6.93M 12.11M 16.03M
Total operating expenses 16.01M 17.27M 14.63M 12.57M 14.09M
Cost of revenue 10.07M 2.81M 2.18M 1.44M 1.87M
Total other income expense net -1.74900M 0.78M 0.10M 0.03M 0.87M
Discontinued operations - - - - -
Net income from continuing ops -8.06300M -5.41300M -8.49800M -1.16000M 2.10M
Net income applicable to common shares -8.06300M -5.41300M -8.49800M -1.16000M 2.10M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 36.92M 31.37M 28.29M 30.08M 34.13M
Intangible assets - - 0.00000M 0.00000M 0.12M
Earning assets - - - - -
Other current assets 1.41M 1.65M 0.19M 0.05M 1.76M
Total liab 15.03M 7.93M 4.15M 3.09M 6.51M
Total stockholder equity 21.89M 23.44M 24.14M 26.99M 27.61M
Deferred long term liab - - - - 0.12M
Other current liab 2.34M 2.30M 0.83M 0.15M 2.47M
Common stock - 57.70M 54.93M 51.19M 51.19M
Capital stock 64.19M - 54.93M 51.19M 51.19M
Retained earnings -55.03700M -46.97400M -41.56100M -32.70000M -31.54000M
Other liab - - 0.17M 0.31M 0.45M
Good will - - - - -
Other assets - - - - 0.12M
Cash 0.50M 0.50M 4.43M 9.21M 6.93M
Cash and equivalents - - - - -
Total current liabilities 5.29M 7.76M 3.98M 2.78M 6.07M
Current deferred revenue - 0.33M 2.07M 1.19M 0.25M
Net debt 9.90M 3.96M -3.69300M -8.33300M -6.16200M
Short term debt - 4.47M 0.74M 0.88M 0.77M
Short long term debt 0.82M - 0.74M 0.88M 0.77M
Short long term debt total - 4.47M 0.74M 0.88M 0.77M
Other stockholder equity - - -13.36800M -18.12600M -19.64900M
Property plant equipment - - 18.55M 16.21M 16.74M
Total current assets 15.52M 10.41M 9.74M 13.87M 17.27M
Long term investments - - - - -
Net tangible assets - - 24.14M 26.99M 27.61M
Short term investments 3.60M - - - -
Net receivables 5.42M 6.57M 2.25M 1.54M 8.12M
Long term debt 9.59M - - - -
Inventory 3.03M 1.68M 1.37M 1.10M 0.45M
Accounts payable 0.75M 0.66M 0.35M 0.55M 2.58M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 12.71M 10.77M 8.50M 7.97M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - -18.54600M -16.21500M -
Deferred long term asset charges - - - - -
Non current assets total 21.40M 20.96M 18.55M 16.21M 16.86M
Capital lease obligations - - - - -
Long term debt total - - 0.00000M 0.00000M 0.00000M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -4.50300M -1.09400M -0.52200M -0.91200M -0.52600M
Change to liabilities - - -1.18600M -1.25400M 0.64M
Total cashflows from investing activities -4.50300M -1.09400M -0.52200M -0.91200M -0.52600M
Net borrowings 4.10M 3.73M -0.14100M 0.02M 0.02M
Total cash from financing activities 10.75M 6.77M 3.64M 0.34M 0.22M
Change to operating activities - - 0.20M 0.28M -0.01000M
Net income -8.06300M -5.41300M -8.49800M -1.16000M 2.10M
Change in cash -0.00100M -3.92900M -4.78100M 2.29M 0.07M
Begin period cash flow 0.50M 4.43M 9.21M 6.93M 6.86M
End period cash flow 0.50M 0.50M 4.43M 9.21M 6.93M
Total cash from operating activities -6.25200M -9.60200M -7.90200M 2.86M 0.37M
Issuance of capital stock 6.65M 3.04M 3.78M 0.32M 0.20M
Depreciation 0.86M 0.93M -1.03900M -1.53600M 1.78M
Other cashflows from investing activities -3.20300M -0.40000M - 0.00000M 0.00000M
Dividends paid - - - - -
Change to inventory -1.34600M -0.30700M 0.27M -0.69800M -0.00900M
Change to account receivables -0.51400M -3.73900M 1.00M 7.10M -3.92000M
Sale purchase of stock 6.65M 3.04M 3.78M 0.32M 0.20M
Other cashflows from financing activities - -1.09400M 1.23M 1.35M 1.09M
Change to netincome - - 0.18M 0.32M 0.28M
Capital expenditures 1.30M 0.69M 0.52M 0.91M 0.53M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -1.82500M -4.39700M 1.27M 6.40M -3.92900M
Stock based compensation - -0.05500M 0.18M 0.32M 0.31M
Other non cash items 2.78M -0.66200M 1.63M 5.56M -3.51300M
Free cash flow -7.55200M -10.29600M -8.42400M 1.95M -0.15600M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
IDT
IDT Australia Ltd		 -0.001 2.70% 0.04 - 4.63 0.83 0.78 1.15 -1.0188
AFP
Aft Pharmaceuticals Ltd		 - -% 3.25 27.08 18.18 1.34 3.71 1.82 16.41
VLS
Vita Life Sciences Ltd		 0.11 4.49% 2.56 13.61 42.73 1.43 2.31 1.04 6.13
LGP
Little Green Pharma Ltd		 - -% 0.09 - 43.29 1.68 0.86 1.76 27.44
SNT
Syntara Ltd		 -0.001 3.85% 0.03 - 20.45 6.51 4.60 6.32 -2.1607

Reports Covered

Stock Research & News

View All

Profile

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States. The company offers microbiological and analytical testing, clinical packaging, and pharmacy services. It also provides medicinal cannabis and psychedelics; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, the company offers mRNA and antibody drug conjugates. Further, the company provides contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.

IDT Australia Ltd

45 Wadhurst Drive, Boronia, VIC, Australia, 3155

Key Executives

Name Title Year Born
Mr. Paul McDonald Interim CEO NA
Mr. Chris Kagiaros Head of People & Culture NA
Dr. David Sparling BVSc (Hons), GDipAppCGov, L.L.B., LLB (Hons) Joint company Sec. NA
Mr. Vasanthakumar Mahendran Interim Chief Financial Officer NA
Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP Company Sec. 1964
Mr. Paul Anthony McDonald Chief Executive Officer NA
Mr. Vasanthakumar Mahendran Chief Financial Officer NA
Mr. Jim Sosic COO & Operations Director NA
Ms. Priscilla Thiyageas Quality Director NA
Ms. Paula Coutts Head of People & Safety NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.